Efficacy of Ozurdex implants as second-line therapy for non-responders to anti-VEGF in retinal vein occlusion-associated macular edema: a retrospective cohort study. [PDF]
Eissa M +4 more
europepmc +1 more source
Pharmacological Treatment for Diabetic Macular Edema: A 2025 Update on Durability and Multi-Target Therapies. [PDF]
Tao Y, Zhang Y, Xu W, Liu G, Liu H.
europepmc +1 more source
Beyond the First Year of Intravitreal Faricimab for Diabetic Macular Oedema: A Single-Centre Experience. [PDF]
Tsilegeridis-Legeris T, Kenawy N.
europepmc +1 more source
Outcomes of intravitreal dexamethasone implant (Ozurdex®) in patients with post-surgical macular edema - a real-world scenario. [PDF]
de Oliveira Júnior EO +3 more
europepmc +1 more source
Inflammatory mechanisms in diabetic retinopathy: pathogenic roles and therapeutic perspectives. [PDF]
Qian HY, Wei XH, Huang JO.
europepmc +1 more source
Anterior Chamber Migration of Dexamethasone Implant in a Patient Implanted with Carlevale Sutureless Scleral Fixation Intraocular Lens: A Case Report. [PDF]
Sejournet L +3 more
europepmc +1 more source
Artificial intelligence-based fluid quantification predicts clinical outcomes in diabetic macular oedema eyes treated with intravitreal dexamethasone implants: DIADEMA project. [PDF]
Franquesa-Garcia F +22 more
europepmc +1 more source
Safety of Long-Acting Intravitreal Hydrogels: A Comprehensive Evaluation of Intraocular Pressure and Retinal Integrity across Rabbit and Non-Human Primate Models. [PDF]
Beathard-Wojan AK +2 more
europepmc +1 more source
Etanercept-induced sarcoidosis presenting with bilateral panuveitis: diagnostic value of ocular signs and therapeutic response to IL-17A inhibition-a case-based review. [PDF]
Bonifazi T, Cerquaglia A, Iaccheri B.
europepmc +1 more source
Extended Real-World Efficacy of Faricimab in Therapy-Resistant Macular Edema Due to Retinal Vein Occlusion: 9-Month Follow-Up Results. [PDF]
Hafner M +6 more
europepmc +1 more source

